Does DATOPOTAMAB DERUXTECAN-DLNK Cause Disease progression? 49 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Disease progression have been filed in association with DATOPOTAMAB DERUXTECAN-DLNK. This represents 29.7% of all adverse event reports for DATOPOTAMAB DERUXTECAN-DLNK.
49
Reports of Disease progression with DATOPOTAMAB DERUXTECAN-DLNK
29.7%
of all DATOPOTAMAB DERUXTECAN-DLNK reports
25
Deaths
8
Hospitalizations
How Dangerous Is Disease progression From DATOPOTAMAB DERUXTECAN-DLNK?
Of the 49 reports, 25 (51.0%) resulted in death, 8 (16.3%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DATOPOTAMAB DERUXTECAN-DLNK. However, 49 reports have been filed with the FAERS database.